Low-level lead exposure, metabolic syndrome, and heart rate variability: The VA Normative Aging Study

Environmental Health Perspectives

Volumn 114, Issue 11, 2006, Pages 1718-1724

  Park, Sung Kyun ^a,d   Schwartz, Joel ^a,b   Weisskopf, Marc ^a   Sparrow, David ^c   Vokonas, Pantel S ^c   Wright, Robert O ^a,b   Coull, Brent ^a   Nie, Huiling ^a,b   Hu, Howard ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autonomic nervous system; Bone lead; Heart rate variability; Hypertension; Metabolic syndrome

Indexed keywords

GLUCOSE; HEMOGLOBIN S; HIGH DENSITY LIPOPROTEIN; LEAD;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOTOXICITY; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HEALTH HAZARD; HEART DEATH; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LEAD BLOOD LEVEL; LEAD POISONING; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PATELLA; PRIORITY JOURNAL; RISK FACTOR; TIBIA; X RAY FLUORESCENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HEART DISEASES; HEART RATE; HUMANS; LEAD; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; PATELLA; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 33750895063     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8992     Document Type: Article

References (48)

1. Ahnve S, Vallin H. 1982. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 65:435-439.
2. Bell B, Rose C, Damon A. 1972. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 3:4-17.
3. Bockelmann I, Pfister EA, McGauran N, Robra BP. 2002. Assessing the suitability of cross-sectional and longitudinal cardiac rhythm tests with regard to identifying effects of occupational chronic lead exposure. J Occup Environ Med 44:59-65.
4. Burger DE, Milder FL, Morsillo PR, Adams BB, Hu H. 1990. Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci 55:287-292.
5. Cheng Y, Schwartz J, Vokonas PS, Weiss ST, Aro A, Hu H. 1998. Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am J Cardiol 82:594-599.
6. Chowdhary S, Ng GA, Nuttall SL, Coote JH, Ross HF, Townend JN. 2002. Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) 102:397-402.
7. Ding Y, Gonick HC, Vaziri ND. 2000. Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens 13:552-555.
8. Dursun N, Arifoglu C, Suer C, Keskinol L. 2005. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels. Biol Trace Elem Res 104:141-149.
9. Eilers PHC, Marx BD. 1996. Flexible smoothing with B-splines and penalties. Stat Sci 11:89-121.
10. Ford ES. 2005. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769-1778.
11. Ford ES, Giles WH, Dietz WH. 2002. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359.
12. Fracasso ME, Perbellini L, Solda S, Talamini G, Franceschetti P. 2002. Lead induced DNA strand breaks in lymphocytes of exposed workers: role of reactive oxygen species and protein kinase C. Mutat Res 515:159-169.
13. Gennart JP, Bernard A, Lauwerys R. 1992. Assessment of thyroid, testes, kidney and autonomic nervous system function in lead-exposed workers. Int Arch Occup Environ Health 64:49-57.
14. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, et al. 2001. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793-1798.
15. Gurer H, Ercal N. 2000. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 29:927-945.
16. Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot M. 2005. Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation 111:3071-3077.
17. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, et al. 1996. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275:1171-1176.
18. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
19. Jhun HJ, Kim H, Paek DM. 2005. The association between blood metal concentrations and heart rate variability: a cross-sectional study. Int Arch Occup Environ Health 78:243-247.
20. Kim R, Landrigan C, Mossmann P, Sparrow D, Hu H. 1997. Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol 146:586-591.
21. Kober TE, Cooper GP. 1976. Lead competitively inhibits calcium-dependent synaptic transmission in the bullfrog sympathetic ganglion. Nature 262:704-705.
22. Korrick SA, Hunter DJ, Rotnitzky A, Hu H, Speizer FE. 1999. Lead and hypertension in a sample of middle-aged women. Am J Public Health 89:330-335.
23. Kristal-Boneh E, Froom P, Harari G, Malik M, Ribak J. 2000. Summer-winter differences in 24 h variability of heart rate. J Cardiovasc Risk 7:141-146.
24. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, et al. 1998. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 21:2116-2122.
25. Lustberg M, Silbergeld E. 2002. Blood lead levels and mortality. Arch Intern Med 162:2443-2449.
26. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. 2004. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:1245-1250.
27. Moller DE, Kaufman KD. 2005. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45-62.
28. Murata K, Araki S. 1991. Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability. Am J Ind Med 20:663-671.
29. Murata K, Araki S, Yokoyama K, Uchida E, Fujimura Y. 1993. Assessment of central, peripheral, and autonomic nervous system functions in lead workers: neuroelectrophysiological studies. Environ Res 61:323-336.
30. Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, et al. 2003. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 289:1523-1532.
31. Oktem F, Arslan MK, Dundar B, Delibas N, Gultepe M, Ergurhan Ilhan I. 2004. Renal effects and erythrocyte oxidative stress in long-term low-level lead-exposed adolescent workers in auto repair workshops. Arch Toxicol 78:681-687.
32. Park SK, O'Neill MS, Vokonas PS, Sparrow D, Schwartz J. 2005. Effects of air pollution on heart rate variability: the VA Normative Aging Study. Environ Health Perspect 113:304-309.
33. Pikkujamsa SM, Huikuri HV, Airaksinen KE, Rantala AO, Kauma H, Lilja M, et al. 1998. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 11:523-531.
34. Foundation for Statistical Computing. 2006. The R Project for Statistical Computing. Available: http://www.r-project.org/ [accessed 22 September 2006].
35. Rosner B. 1983. Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165-172.
36. Sandhir R, Gill KD. 1994. Alterations in calcium homeostasis on lead exposure in rat synaptosomes. Mol Cell Biochem 131:25-33.
37. Sandhir R, Gill KD. 1995. Effect of lead on lipid peroxidation in liver of rats. Biol Trace Elem Res 48:91-97.
38. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. 2003. Hypertension, blood pressure, and heart rate variability. The Atherosclerosis Risk in Communities (ARIC) study. Hypertension 42:1106-1111.
39. Schwartz J. 1991. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect 91:71-75.
40. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. 1998. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 32:293-297.
41. Tapanainen JM, Thomsen PE, Kober L, Torp-Pedersen C, Makikallio TH, Still AM, et al. 2002. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 90:347-352.
42. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065.
43. Teruya K, Sakurai H, Omae K, Higashi T, Muto T, Kaneko Y. 1991. Effect of lead on cardiac parasympathetic function. Int Arch Occup Environ Health 62:549-553.
44. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D, et al. 2004. Lead, diabetes, hypertension, and renal function: the Normative Aging Study. Environ Health Perspect 112:1178-1182.
45. Tsuji H, Larson MG, Venditti FJ, Manders ES, Evans JC, Feldman CL, et al. 1996. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 94:2850-2855.
46. Vaziri ND. 2002. Pathogenesis of lead-induced hypertension: role of oxidative stress. J Hypertens 20(suppl 3):S15-S20.
47. Wood SN. 2000. Modelling and smoothing parameter estimation with multiple quadratic penalties. J R Statist Soc B 62:413-428.
48. Ye XB, Fu H, Zhu JL, Ni WM, Lu YW, Kuang XY, et al. 1999. A study on oxidative stress in lead-exposed workers. J Toxicol Environ Health A 57:161-172.